dysbiosis

Enteric pathogens as active drivers of dysbiosis: lessons from Bacillus cereus and experimental models of the gut microbiota

Emilia Ghelardi, Professor of Microbiology and Molecular Microbiology at the University of Pisa, explains how pathogens can actively disrupt the integrity of the commensal community.

Resetting the immune system: HMOs as a promising treatment for Gut-Brain Axis disorders

Emil Chuang, Chief Medical Officer at Intrinsic Medicine, explores the growing understanding of gut-brain axis disorders and the potential of Human Milk Oligosaccharides (HMOs) in their treatment. 

The vaginal microbiome

Understanding the vaginal microbiome is essential not only for treating gynecological conditions but also for preventing them and promoting overall well-being.

The role of gut microbiota imbalance in gut-liver axis dysfunction and cancer progression

Professor Maria Rescigno explores the critical role of the gut microbiota in maintaining intestinal barrier integrity and its implications for health. 

Microbiota linked to susceptibility to necrotizing enterocolitis in preemies

The results also indicate that the hospital environment influences the gut bacteria of preterm infants, highligting the importance of managing antibiotics and medications to support a healthy gut development.

Microbiome’s implications in recurrent pregnancy loss

A systematic review recently published in the Journal of Reproductive Immunology provides a comprehensive overview of the emerging role of the microbiome in recurrent pregnancy loss (RPL).

Dysbiosis may be involved in epilepsy drug-resistance

Dysbiosis may be involved in drug-resistant epilepsy and the restoration of gut microbiota may be a novel therapeutic method for drug-resistant epilepsy.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top